Back to Browse Journals » Vascular Health and Risk Management » Volume 3 » Issue 1

Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2

Authors Allen J Taylor, Daming Zhu, Lance E Sullenberger, Hyun J Lee, Jeannie K Lee, Karen A Grace

Published 15 March 2007 Volume 2007:3(1) Pages 159—164

Allen J Taylor, Daming Zhu, Lance E Sullenberger, Hyun J Lee, Jeannie K Lee, Karen A Grace

Cardiology Service, Walter Reed Army Medical Center, Washington, DC, USA

Background: We previously reported in a placebo-controlled study that extended-release niacin slowed the progression of carotid atherosclerosis when added to statin monotherapy. This analysis examines the relationship between glycemic status and the effects of niacin on common carotid intima-media thickness (CIMT) and HDL cholesterol.

Methods: Post-hoc, subgroup analysis of ARBITER 2, a randomized, placebo-controlled trial of once-daily extended-release niacin (1000 mg) added to background statin therapy in 167 patients (mean age 67 years) with known coronary heart disease. The primary analysis was a comparison of the primary endpoint, the change in CIMT, between participants with either normal glycemic status, diabetes mellitus (DM) or the metabolic syndrome (MS).

Results: Baseline cardiovascular risk variables were significantly worse in those with abnormal glycemic status, particularly among subjects with MS. Niacin increased HDL-C to a similar degree (~20%) across normals, DM and MS. Placebo-treated patients had the greatest CIMT progression, regardless of glycemic status. The lowest progression rate was observed in niacin treated patients with normal glycemic status. Among all niacin treated subjects, there was a significant linear relationship between change in CIMT and change in HDL-C (r = –0.16; p = 0.05), which was of similar magnitude in subgroups with normal glycemic status (r = –0.23; p = 0.08) and DM (r = –0.22; p = 0.17). In those with MS, there was no relationship between changes in HDL and CIMT, (r = 0.11; p = 0.44), whereas blood glucose was positive correlated to change in CIMT (r = 0.30; p = 0.04). In multivariable linear models controlling for MS characteristics and blood glucose changes, only the change in HDL independently predicted change in CIMT.

Conclusions: During niacin treatment, increases in HDL-C are related to changes in CIMT in the setting of both normal glycemic status and diabetes mellitus.

Keywords: atherosclerosis, risk factors, lipids, diabetes mellitus

Download Article [PDF] 

Readers of this article also read:

Systematic review of the association between Alzheimer’s disease and chronic glaucoma

Tsilis AG, Tsilidis KK, Pelidou SH, Kitsos G

Clinical Ophthalmology 2014, 8:2095-2104

Published Date: 13 October 2014

Is higher body temperature beneficial in ischemic stroke patients with normal admission CT angiography of the cerebral arteries?

Kvistad CE, Khanevski A, Nacu A, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2014, 10:49-54

Published Date: 21 January 2014

Characterization of the vasodilatory action of testosterone in the human pulmonary circulation

Alyson M Smith, Robert T Bennett, T Hugh Jones, Mike E Cowen, Kevin S Channer, Richard D Jones

Vascular Health and Risk Management 2008, 4:1459-1466

Published Date: 5 December 2008

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review

Andrea Russo, Ivano Riva, Teodoro Pizzolante, Federico Noto, Luciano Quaranta

Clinical Ophthalmology 2008, 2:897-905

Published Date: 5 December 2008

The characteristics of keratomycosis by Beauveria bassiana and its successful treatment with antimycotic agents

Hiroko Sonoyama, Kaoru Araki-Sasaki, Shigeyasu Kazama, Tsutomu Kawasaki, Hidenao Ideta, et al

Clinical Ophthalmology 2008, 2:675-678

Published Date: 12 September 2008

Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients

Lyudmila G Nikolaeva, Tatyana V Maystat, Lilia A Masyuk, Volodymyr S Pylypchuk, Yuri L Volyanskii, Galyna A Kutsyna

Drug Design, Development and Therapy 2008, 2:87-93

Published Date: 1 May 2008

Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population

Deirdre F Waterhouse, Ronan A Cahill, Frances Sheehan, CJ McCreery

Vascular Health and Risk Management 2008, 4:177-187

Published Date: 8 February 2008